These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21239064)

  • 1. Immunoprotection against toxic biomarkers is retained during Parkinson's disease progression.
    Gruden MA; Sewell RD; Yanamandra K; Davidova TV; Kucheryanu VG; Bocharov EV; Bocharova OA; Polyschuk VV; Sherstnev VV; Morozova-Roche LA
    J Neuroimmunol; 2011 Apr; 233(1-2):221-7. PubMed ID: 21239064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between protective immunity to α-synuclein aggregates, oxidative stress and inflammation.
    Gruden MA; Yanamandra K; Kucheryanu VG; Bocharova OR; Sherstnev VV; Morozova-Roche LA; Sewell RDE
    Neuroimmunomodulation; 2012; 19(6):334-342. PubMed ID: 22986484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune reactivity towards insulin, its amyloid and protein S100B in blood sera of Parkinson's disease patients.
    Wilhelm KR; Yanamandra K; Gruden MA; Zamotin V; Malisauskas M; Casaite V; Darinskas A; Forsgren L; Morozova-Roche LA
    Eur J Neurol; 2007 Mar; 14(3):327-34. PubMed ID: 17355556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementias.
    Maetzler W; Berg D; Synofzik M; Brockmann K; Godau J; Melms A; Gasser T; Hörnig S; Langkamp M
    J Alzheimers Dis; 2011; 26(1):171-9. PubMed ID: 21593566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lowered serum amyloid-β1-42 autoantibodies in individuals with lifetime depression.
    Maetzler W; Langkamp M; Lerche S; Godau J; Brockmann K; Gaenslen A; Huber H; Wurster I; Niebler R; Eschweiler GW; Berg D
    J Alzheimers Dis; 2012; 32(1):95-100. PubMed ID: 22766733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal inoculation with α-synuclein aggregates evokes rigidity, locomotor deficits and immunity to such misfolded species as well as dopamine.
    Gruden MA; Davidova TV; Yanamandra K; Kucheryanu VG; Morozova-Roche LA; Sherstnev VV; Sewell RD
    Behav Brain Res; 2013 Apr; 243():205-12. PubMed ID: 23333843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral vector-mediated overexpression of α-synuclein as a progressive model of Parkinson's disease.
    Ulusoy A; Decressac M; Kirik D; Björklund A
    Prog Brain Res; 2010; 184():89-111. PubMed ID: 20887871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased S100B+ NK cell counts in acutely ill schizophrenia patients are correlated with the free cortisol index, but not with S100B serum levels.
    Steiner J; Westphal S; Schroeter ML; Schiltz K; Jordan W; Müller UJ; Bernstein HG; Bogerts B; Schmidt RE; Jacobs R
    Brain Behav Immun; 2012 May; 26(4):564-7. PubMed ID: 22326439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease.
    Shannon KM; Keshavarzian A; Mutlu E; Dodiya HB; Daian D; Jaglin JA; Kordower JH
    Mov Disord; 2012 May; 27(6):709-15. PubMed ID: 21766334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparable autoantibody serum levels against amyloid- and inflammation-associated proteins in Parkinson's disease patients and controls.
    Maetzler W; Apel A; Langkamp M; Deuschle C; Dilger SS; Stirnkorb JG; Schulte C; Schleicher E; Gasser T; Berg D
    PLoS One; 2014; 9(2):e88604. PubMed ID: 24586351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naturally occurring α-synuclein autoantibody levels are lower in patients with Parkinson disease.
    Besong-Agbo D; Wolf E; Jessen F; Oechsner M; Hametner E; Poewe W; Reindl M; Oertel WH; Noelker C; Bacher M; Dodel R
    Neurology; 2013 Jan; 80(2):169-75. PubMed ID: 23255825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond α-synuclein transfer: pathology propagation in Parkinson's disease.
    Hansen C; Li JY
    Trends Mol Med; 2012 May; 18(5):248-55. PubMed ID: 22503115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?
    Chu Y; Kordower JH
    Neurobiol Dis; 2007 Jan; 25(1):134-49. PubMed ID: 17055279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of some peripheral blood lymphocyte subsets in relation to Borrelia burgdorferi antibodies in patients with Lyme disease.
    Zajkowska JM; Hermanowska-Szpakowicz T; Wysocka J; Kondrusik M; Pancewicz SA; Grygorczuk S
    Rocz Akad Med Bialymst; 2000; 45():184-98. PubMed ID: 11712430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
    J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model.
    Febbraro F; Andersen KJ; Sanchez-Guajardo V; Tentillier N; Romero-Ramos M
    Exp Neurol; 2013 Sep; 247():45-58. PubMed ID: 23531432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cells from patients with Parkinson's disease recognize α-synuclein peptides.
    Sulzer D; Alcalay RN; Garretti F; Cote L; Kanter E; Agin-Liebes J; Liong C; McMurtrey C; Hildebrand WH; Mao X; Dawson VL; Dawson TM; Oseroff C; Pham J; Sidney J; Dillon MB; Carpenter C; Weiskopf D; Phillips E; Mallal S; Peters B; Frazier A; Lindestam Arlehamn CS; Sette A
    Nature; 2017 Jun; 546(7660):656-661. PubMed ID: 28636593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.